Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SILKIS (calcitriol)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SILKIS (calcitriol)

Medicine - Posted on Feb 03 2020 - Updated on Feb 03 2020
Active substance (DCI)
  • calcitriol
history (5)
  • 1/8/20

    SILKIS (calcitriol)

    Maintien du remboursement. Avis favorable au maintien du remboursement dans le traitement topique du psoriasis en plaques lé...
    icône flèche
  • 12/17/14

    SILKIS (calcitriol)

    SILKIS (calcitriol)
    icône flèche
  • 1/7/09

    SILKIS (calcitriol)

    SILKIS (calcitriol)
    icône flèche
  • 5/9/07

    SILKIS (calcitriol)

    SILKIS (calcitriol)
    icône flèche
  • 2/19/03

    SILKIS 3 microgrammes/gramme, pommade, (tube de 30 g, 100 g)

    SILKIS 3 microgrammes/gramme, pommade, (tube de 30 g, 100 g)
    icône flèche
Technical information
ATC code
  • D05AX03
Manufacturer
GALDERMA INTERNATIONAL
Presentation

SILKIS 3 microgrammes/g, pommade (code CIS : 62597239)
1 tube aluminium verni de 30 g - Code  CIP : 34009 351 116 1 6
1 tube aluminium verni de 100 g - Code CIP : 34009 351 117 8 4

All our publications
    Drug therapy Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
T6f6DEc6LjCzvEbk